City Health GP Federation Joint Working Executive Summary.

Identification and optimisation of care for respiratory patients across City Health GP Federation through the delivery of a data-led quality improvement programme in primary care

This project between Boehringer Ingelheim Ltd (BIL) and City Health GP Federation aims to improve patient health outcomes and reduce unscheduled COPD-related healthcare resource use (including emergency call-outs and other non-elective care) in a cohort of high-risk COPD patients over the 2020-21 Winter Period.

Rates of early death (before the age of 75) from respiratory disease in Bradford District are amongst the highest in England and the second highest in Yorkshire & Humber. On average there are 180 deaths per year due to respiratory in the under 75s with the main cause of death being COPD and pneumonia.1

The Joint Working project with BIL utilising PRIMIS GRASP-COPD will support City Health GP Federation to:

  • Identify the top 30 % frequent COPD admitters to hospital

  • Reduce the unscheduled COPD-related healthcare resource use within the Federation by introducing timely, high value interventions

  • Help provide specialist, dedicated education and training support into primary care

  • Reduce the undiagnosed COPD population within the federation

  • Optimise respiratory treatments in line with local guidelines and environmental targets

  • Enable diagnosed COPD patients in City Health GP Federation to better self-manage their disease with appropriate support from primary care services close to home

The pilot started in October 2020 and is anticipated to run until the end of January 2022.

BIL is pleased to collaborate with City Health GP Federation to design and deliver a data-led quality improvement programme in respiratory care implemented through a specialist pharmacist team across the City Health GP Federation practices. 

References:

1. Bradford Joint Strategic Needs Assessment. Chapter 4. 2019. [Online]. Available at:  https://jsna.bradford.gov.uk/documents/People%20are%20living%20their%20lives%20well%20and%20ageing%20well/4.3%20Ill%20Health/Respiratory%20disease.pdf  (Last accessed September 2020)

 

NP-GB-102233  V2   November  2022